Quick Takeaways
- Rubric Capital Management LP filed SCHEDULE 13G/A for Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI).
- Disclosed ownership: 2.9%.
- Date of event: 31 Dec 2025.
Rubric Capital Management LP - 31 Dec 2025 SCHEDULE 13G/A Report for Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI)
- Filing Manager
- Rubric Capital Management LP
- Reporting Manager
- Rubric Capital Management LP
- Symbol
- TRVI
- Shares outstanding
- 128,120,714 shares
- Disclosed Ownership
- 3,766,749 shares
- Ownership
- 2.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2026, 16:26:05 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 09 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Rubric Capital Management LP disclosed 2.9% ownership in Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 09 Jul 2025.
- Current filing was accepted on 13 Feb 2026, 16:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Rubric Capital Management LP | 2.9% | 3,766,749 | 0 | 3,766,749 | /s/ Michael Nachmani | Michael Nachmani / Chief Operating Officer | |
| David Rosen | 2.9% | 3,766,749 | 0 | 3,766,749 | /s/ David Rosen | David Rosen / Individually |